NOX1 and hypertensive disorder: It has been reported that Nox1 overexpression in SMCs augments Ang II-induced hypertension and smooth muscle hypertrophy; moreover, the deletion of Nox1 alleviates elevated blood pressure and maintains endothelium-dependent vascular relaxation in Ang II-infused mice [21,22].